PSFG
BSX icon

Park Square Financial Group’s Boston Scientific BSX Stock Holding History

Park Square Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,836
Closed -$197K – 356
2025
Q2 		$197K Sell
1,836
-230
-11% -$23.3K 0.14% 107
2025
Q1 		$208K Buy
2,066
+103
+5% +$10.4K 0.17% 80
2024
Q4 		$175K Buy
+1,963
New +$173K 0.12% 106

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Park Square Financial Group's BSX Position: Q3 2025 in Review

Park Square Financial Group sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 1,836 shares — an estimated $197K sold.

Park Square Financial Group first reported a position in BSX in Q4 2024 and held it in 3 quarters. The position peaked at $208K in Q1 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Park Square Financial Group reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Park Square Financial Group sold 1,836 Boston Scientific shares in Q3 2025, an estimated $197K.
  • Park Square Financial Group first reported a position in Boston Scientific in Q4 2024 and held it in 3 quarters.
  • Park Square Financial Group's Boston Scientific position peaked at $208K in Q1 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Park Square Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.